Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
Total Valuation
West Pharmaceutical Services has a market cap or net worth of $16.96B. The enterprise value is $16.49B.
Market Cap$16.96B
Enterprise Value$16.49B
Share Statistics
West Pharmaceutical Services has 72,021,490 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding72,021,490
Owned by Insiders0.58%
Owned by Institutions27.00%
Financial Efficiency
West Pharmaceutical Services’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 13.62%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)13.62%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee289.97K
Profits Per Employee46.58K
Employee Count10,600
Asset Turnover0.72
Inventory Turnover4.44
Valuation Ratios
The current PE Ratio of West Pharmaceutical Services is 40.3. West Pharmaceutical Services’s PEG ratio is 34.00.
PE Ratio40.3
PS Ratio6.47
PB Ratio6.26
Price to Fair Value6.26
Price to FCF42.42
Price to Operating Cash Flow22.55
PEG Ratio34.00
Income Statement
In the last 12 months, West Pharmaceutical Services had revenue of 3.07B and earned 493.70M in profits. Earnings per share was 6.83.
Revenue3.07B
Gross Profit1.10B
Operating Income617.40M
Pretax Income615.30M
Net Income493.70M
EBITDA723.60M
Earnings Per Share (EPS)6.83
Cash Flow
In the last 12 months, operating cash flow was 754.80M and capital expenditures -285.90M, giving a free cash flow of 468.90M billion.
Operating Cash Flow754.80M
Free Cash Flow468.90M
Free Cash Flow per Share6.51
Dividends & Yields
West Pharmaceutical Services pays an annual dividend of $0.22, resulting in a dividend yield of 0.32%
Dividend Per Share$0.22
Dividend Yield0.32%
Payout Ratio12.02%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.71
52-Week Price Change2.09%
50-Day Moving Average250.62
200-Day Moving Average251.37
Relative Strength Index (RSI)42.13
Average Volume (3m)1.00M
Important Dates
West Pharmaceutical Services upcoming earnings date is Apr 23, 2026, Before Open (Confirmed).
Last Earnings DateFeb 12, 2026
Next Earnings DateApr 23, 2026
Ex-Dividend Date―
Financial Position
West Pharmaceutical Services as a current ratio of 3.02, with Debt / Equity ratio of 10.11%
Current Ratio3.02
Quick Ratio2.34
Debt to Market Cap0.02
Net Debt to EBITDA-0.52
Interest Coverage Ratio1.03K
Taxes
In the past 12 months, West Pharmaceutical Services has paid 121.60M in taxes.
Income Tax121.60M
Effective Tax Rate0.20
Enterprise Valuation
West Pharmaceutical Services EV to EBITDA ratio is 26.97, with an EV/FCF ratio of 41.63.
EV to Sales6.35
EV to EBITDA26.97
EV to Free Cash Flow41.63
EV to Operating Cash Flow25.86
Balance Sheet
West Pharmaceutical Services has $791.30M in cash and marketable securities with $321.10M in debt, giving a net cash position of $470.20M billion.
Cash & Marketable Securities$791.30M
Total Debt$321.10M
Net Cash$470.20M
Net Cash Per Share$6.53
Tangible Book Value Per Share$42.30
Margins
Gross margin is 35.89%, with operating margin of 20.09%, and net profit margin of 16.06%.
Gross Margin35.89%
Operating Margin20.09%
Pretax Margin20.02%
Net Profit Margin16.06%
EBITDA Margin23.54%
EBIT Margin19.49%
Analyst Forecast
The average price target for West Pharmaceutical Services is $310.28, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$310.28
Price Target Upside31.78% Upside
Analyst ConsensusStrong Buy
Analyst Count11
Revenue Growth Forecast4.90%
EPS Growth Forecast-0.26%